Lanean...
BRAF-inhibition and tumor immune suppression
As BRAF(V600E)-inhibitors become standard treatment for many metastatic melanoma patients, research has begun to elucidate their impact on the tumor immune landscape. Here, we highlight our recent studies demonstrating the ability of melanoma cell-intrinsic BRAF(V600E)-inhibition to selectively redu...
Gorde:
| Argitaratua izan da: | Oncoimmunology |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404921/ https://ncbi.nlm.nih.gov/pubmed/25949884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.988039 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|